• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Inspira Technologies Appoints Yoav Rozanovich as Chief Business Officer to Drive Immediate Revenue Growth and Quantum Expansion

    4/14/26 8:01:00 AM ET
    $IINN
    $NNDM
    $SSYS
    Medical/Dental Instruments
    Health Care
    Electrical Products
    Technology
    Get the next $IINN alert in real time by email

    RA'ANANA, Israel, April 14, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd (NASDAQ:IINN, IINNW)) ("Inspira Technologies" or the "Company") today announced the appointment of Mr. Yoav Rozanovich as Chief Business Officer ("CBO") of Inspira Technologies, reinforcing its commercial execution capabilities following its expansion into quantum computing connectivity and the acquisition of the Additive Manufacturing of Electronics ("AME") business from Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension").

    Proven Commercial Leadership

    Mr. Rozanovich brings international experience across additive manufacturing, advanced electronics, and complex systems integration. From November 2021 to April 2026, Mr. Rozanovich served as VP of Global Customer Success at Nano Dimension, where he led global sales and customer operations for advanced electronics manufacturing platforms. Earlier in his career, he held senior roles in operations and systems integration at industry leaders including Stratasys Ltd. (NASDAQ:SSYS) and Orbotech Ltd.

    Immediate Revenue Focus and Scalable Growth

    As CBO, Mr. Rozanovich will lead Inspira Technologies' commercial strategy with a clear focus on near-term revenue execution and long-term market expansion:

    • Immediate Revenue Integration - Overseeing the transition of the active, revenue-generating AME operations, ensuring continuity of existing contracts and immediate contribution to cash flow.
    • Acceleration of Existing Business - Driving forward the current AME sales pipeline while optimizing conversion of the existing global customer base.
    • Expansion into Quantum Markets - Building a new revenue pipeline around Inspira Technologies' quantum computing connectivity solutions, targeting a rapidly emerging multibillion-dollar market.
    • Strategic Partnerships - Establishing alliances across the quantum computing and advanced electronics ecosystems to position Inspira Technologies within critical industry infrastructure layers.



    Dagi Ben-Noon, Chief Executive Officer of Inspira Technologies, commented:

    "Yoav joins Inspira Technologies at a pivotal moment as we transition from strategic positioning to commercial execution. His deep experience and direct familiarity with the AME business provide immediate leverage in converting our existing assets into revenue, while positioning the Company to capture significant opportunities in the evolving quantum computing market."

    Mr. Rozanovich added:

    "The combination of an active, revenue-generating AME platform and the growing demand for quantum computing infrastructure creates a unique opportunity. My focus is on executing a seamless commercial transition, accelerating current revenue streams, and leveraging existing industry relationships to drive immediate and scalable growth."

    About Inspira Technologies

    Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN, IINNW)) is a technology company focused on solving the most critical physical and hardware bottlenecks in quantum computing connectivity. Inspira develops unique quantum connectivity solutions designed for high-density, thermally optimized operation in dilution cryostats, a prerequisite for scaling quantum systems beyond current physical limitations. Additionally, the Company continues to advance its medical technology portfolio, including its respiratory support and blood monitoring platforms under a dedicated business unit. For more information, please visit: www.q-trex.com and www.inspira-technologies.com

    Forward-Looking Statement Disclaimer

    This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses Mr. Rozanovich's expected contributions, focus and impact in his role as the Company's Chief Business Officer, the Company's focus on near-term revenue execution and long-term market expansion, the anticipated integration of the AME commercial operations and customer accounts, the potential to build new revenue streams from the Company's quantum computing connectivity solutions, the ability to develop strategic alliances and partnerships across the quantum computing and advanced electronics ecosystem, the Company's transition from strategic positioning to commercial execution and conversion of its existing assets into revenue, while positioning the Company to capture significant opportunities in the evolving quantum computing market. These forward-looking statements and their implications are based solely on the current expectations of the Company's management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading "Risk Factors" in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the "SEC"), which is available on the SEC's website at www.sec.gov.

    Company Contact

    Inspira Technologies

    Email: info@inspirao2.com

    Phone: +972-9-9664485

    Investor Relations Contact

    Arx Investor Relations

    North American Equities Desk

    inspira@arxhq.com



    Primary Logo

    Get the next $IINN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IINN
    $NNDM
    $SSYS

    CompanyDatePrice TargetRatingAnalyst
    Stratasys Ltd.
    $SSYS
    2/13/2024$24.00Overweight
    Cantor Fitzgerald
    Stratasys Ltd.
    $SSYS
    1/4/2023$15.00Hold → Buy
    Needham
    Stratasys Ltd.
    $SSYS
    11/8/2022Underperform → Mkt Perform
    William Blair
    Stratasys Ltd.
    $SSYS
    8/17/2022$24.00Outperform
    Credit Suisse
    Stratasys Ltd.
    $SSYS
    5/17/2022$25.00 → $23.00Underweight → Neutral
    JP Morgan
    Stratasys Ltd.
    $SSYS
    2/24/2022$30.00Hold → Buy
    Cross Research
    Stratasys Ltd.
    $SSYS
    11/4/2021Neutral → Underweight
    JP Morgan
    Stratasys Ltd.
    $SSYS
    11/4/2021Overweight → Neutral
    JP Morgan
    More analyst ratings

    $IINN
    $NNDM
    $SSYS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board

    WALTHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") today announced the appointment of Moshe Rozenbaum as Interim Chief Executive Officer ("CEO"), effective immediately. The Company’s Board of Directors (the "Board") has also appointed Phillip Borenstein as Chairman of the Board. Mr. Rozenbaum will work closely with the Board and the Company’s leadership to support business continuity while the Board evaluates the Company’s strategic priorities and opportunities moving forward. Phillip Borenstein, Chairman of the Board, commented, "On behalf of myself and the entire Board of Directors, we are pleased to appoint

    7/21/26 4:05:00 PM ET
    $NNDM
    $LFWD
    Electrical Products
    Technology
    Industrial Specialties
    Health Care

    Nano Dimension and Murchinson Announce Agreement to Reconstitute the Company’s Board of Directors

    WALTHAM, Mass., July 20, 2026 (GLOBE NEWSWIRE) -- In connection with the upcoming July 31, 2026, Extraordinary General Meeting of Shareholders (the "July EGM"), Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano," or the "Company") and Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson") today jointly announced a settlement agreement. Under the terms of the agreement executed on July 17, the July EGM will be cancelled. Messrs. Pons, Rosensweig, Sriubas and Stehlin (collectively, the "Departing Directors") resigned from the Board and all their positions at Nano. The directors nominated by Murchinson for the July EGM — Messrs. Fruc

    7/20/26 8:30:00 AM ET
    $NNDM
    Electrical Products
    Technology

    QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director

    Ness Ziona, Israel, July 17, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (NASDAQ:QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure, today announced that on July 14, 2026, its Board of Directors (the "Board") appointed Dr. Shlomit Chappel-Ram as an independent director, effective immediately. Dr. Chappel-Ram previously served as Vice President of R&D at Nano Dimension Ltd. (NASDAQ:NNDM), where she led multidisciplinary teams spanning materials, formulations, chemistry, physics, process engineering, mechanics, software, hardware, and electronics. She also co-authored peer-reviewed IEEE research o

    7/17/26 8:30:00 AM ET
    $IINN
    $NNDM
    Medical/Dental Instruments
    Health Care
    Electrical Products
    Technology

    $IINN
    $NNDM
    $SSYS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Stratasys with a new price target

    Cantor Fitzgerald initiated coverage of Stratasys with a rating of Overweight and set a new price target of $24.00

    2/13/24 6:45:02 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    Stratasys upgraded by Needham with a new price target

    Needham upgraded Stratasys from Hold to Buy and set a new price target of $15.00

    1/4/23 7:56:13 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    Stratasys upgraded by William Blair

    William Blair upgraded Stratasys from Underperform to Mkt Perform

    11/8/22 7:27:14 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    $IINN
    $NNDM
    $SSYS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    COO Shabtay Abraham was granted 550,000 units of Ordinary Shares, increasing direct ownership by 41% to 1,882,713 units (SEC Form 4)

    4 - QTREX Quantum Ltd. (0001837493) (Issuer)

    7/15/26 7:00:24 AM ET
    $IINN
    Medical/Dental Instruments
    Health Care

    Chief Business Officer Rozanovich Yoav was granted 550,000 units of Ordinary Shares (SEC Form 4)

    4 - QTREX Quantum Ltd. (0001837493) (Issuer)

    7/14/26 5:45:09 PM ET
    $IINN
    Medical/Dental Instruments
    Health Care

    Chief Technology Officer Yechezkely Hayon Daniella was granted 550,000 units of Ordinary Shares, increasing direct ownership by 71% to 1,330,000 units (SEC Form 4)

    4 - QTREX Quantum Ltd. (0001837493) (Issuer)

    7/14/26 5:43:17 PM ET
    $IINN
    Medical/Dental Instruments
    Health Care

    $IINN
    $NNDM
    $SSYS
    SEC Filings

    View All

    SEC Form F-1 filed by Inspira Technologies Oxy B.H.N. Ltd.

    F-1 - QTREX Quantum Ltd. (0001837493) (Filer)

    7/21/26 5:26:02 PM ET
    $IINN
    Medical/Dental Instruments
    Health Care

    Nano Dimension Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Changes in Control of Registrant, Submission of Matters to a Vote of Security Holders

    8-K - Nano Dimension Ltd. (0001643303) (Filer)

    7/21/26 4:56:32 PM ET
    $NNDM
    Electrical Products
    Technology

    SEC Form 6-K filed by Inspira Technologies Oxy B.H.N. Ltd.

    6-K - QTREX Quantum Ltd. (0001837493) (Filer)

    7/21/26 4:05:26 PM ET
    $IINN
    Medical/Dental Instruments
    Health Care

    $IINN
    $NNDM
    $SSYS
    Leadership Updates

    Live Leadership Updates

    View All

    Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board

    WALTHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") today announced the appointment of Moshe Rozenbaum as Interim Chief Executive Officer ("CEO"), effective immediately. The Company’s Board of Directors (the "Board") has also appointed Phillip Borenstein as Chairman of the Board. Mr. Rozenbaum will work closely with the Board and the Company’s leadership to support business continuity while the Board evaluates the Company’s strategic priorities and opportunities moving forward. Phillip Borenstein, Chairman of the Board, commented, "On behalf of myself and the entire Board of Directors, we are pleased to appoint

    7/21/26 4:05:00 PM ET
    $NNDM
    $LFWD
    Electrical Products
    Technology
    Industrial Specialties
    Health Care

    QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director

    Ness Ziona, Israel, July 17, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (NASDAQ:QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure, today announced that on July 14, 2026, its Board of Directors (the "Board") appointed Dr. Shlomit Chappel-Ram as an independent director, effective immediately. Dr. Chappel-Ram previously served as Vice President of R&D at Nano Dimension Ltd. (NASDAQ:NNDM), where she led multidisciplinary teams spanning materials, formulations, chemistry, physics, process engineering, mechanics, software, hardware, and electronics. She also co-authored peer-reviewed IEEE research o

    7/17/26 8:30:00 AM ET
    $IINN
    $NNDM
    Medical/Dental Instruments
    Health Care
    Electrical Products
    Technology

    Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

    WALTHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") and Infinite Epigenetics™ ("Infinite Epigenetics," "Infinite") today issued the following shareholder update to provide additional detail on the proposed business combination announced on June 15, 2026. The Company has carefully reviewed Murchinson's recent letter regarding the proposed transaction with Infinite. While we welcome shareholder engagement and are committed to transparency, the final details of the transaction are still being negotiated. However, we would like to address specific questions posed by Murchinson, contextualize the Infinite story and com

    6/16/26 7:43:26 PM ET
    $NNDM
    Electrical Products
    Technology

    $IINN
    $NNDM
    $SSYS
    Financials

    Live finance-specific insights

    View All

    Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

    Believes the Proposed Transaction Represents a Misallocation of Corporate Resources That Would Significantly Dilute Existing Shareholders Finds It Deeply Concerning That This Morning's Conference Call Offered Shareholders Little Beyond Buzzwords and Provided No Opportunity to Ask Questions Regarding a Transaction That Materially Impacts the Future of the Company Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano" or the "Company"), today commented on Nano's announcement that it has signed a non-binding term

    6/15/26 5:55:00 PM ET
    $NNDM
    Electrical Products
    Technology

    Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

    Nano Dimension Conducted a Rigorous Multi-Month Strategic Review, Assessing Approximately 20 Companies Before Selecting Infinite Epigenetics as the Most Compelling Path to Long-Term Value CreationProposed Combination Would Deploy Nano Dimension's Capital Base and Nasdaq listing into a High-Growth Healthcare AI OpportunityExisting Nano Shareholders Expected to Retain Meaningful Minority Ownership in Combined Company on a Stated Value for Nano Dimension's Shares that Reflects a 20% Premium to Nano Dimension's Estimated Net Cash at ClosingInfinite Epigenetics Transaction Value of $890 million Infinite Epigenetics Targets a $90B+ U.S. Clinical Diagnostics Market Opportunity Across its Core Disea

    6/15/26 7:27:56 AM ET
    $NNDM
    Electrical Products
    Technology

    Murchinson Invites Fellow Nano Dimension Shareholders to an Investor Call to Discuss the Current State of the Company

    It Is Time to Talk About Nano Dimension Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano" or the "Company"), today announced it will host an investor conference call to discuss the Company's so-called strategic review, Chairman Bob Pons' role in the "review process," and other concerns related to the Company's business and corporate governance. After eight months of limited progress and minimal communication from Nano regarding its strategic review, Murchinson believes shareholders deserve a constructive

    5/26/26 5:00:00 PM ET
    $NNDM
    Electrical Products
    Technology

    $IINN
    $NNDM
    $SSYS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Inspira Technologies Oxy B.H.N. Ltd.

    SC 13G/A - Inspira Technologies OXY B.H.N. Ltd (0001837493) (Subject)

    11/14/24 4:08:42 PM ET
    $IINN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Stratasys Ltd.

    SC 13G/A - STRATASYS LTD. (0001517396) (Subject)

    11/14/24 6:18:58 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SC 13G/A filed by Stratasys Ltd.

    SC 13G/A - STRATASYS LTD. (0001517396) (Subject)

    11/13/24 4:30:24 PM ET
    $SSYS
    Computer peripheral equipment
    Technology